Missouri judge approves $7.25 billion Bayer Roundup settlement

2 min read
Source: AP News
Missouri judge approves $7.25 billion Bayer Roundup settlement
Photo: AP News
TL;DR

A Missouri judge approved a $7.25 billion settlement between Bayer and thousands of cancer patients alleging that the herbicide Roundup causes non-Hodgkin lymphoma. The deal resolves claims from current and future victims, with individual payouts averaging between $10,000 and $165,000 depending on age, usage, and severity. Bayer denies the product causes cancer but accepted the deal to limit litigation costs and avoid potential bankruptcy. The settlement follows a Supreme Court ruling that barred state court claims over failure to warn, shifting the legal landscape for these cases.

Key points

  • Bayer will pay up to $7.25 billion over 21 years to resolve Roundup cancer claims.
  • Individual payouts range from $10,000 to $165,000 based on factors like age and exposure.
  • The settlement covers both current patients and those diagnosed in the future.
  • Bayer denies Roundup causes cancer but faced mounting litigation costs.
  • A Supreme Court ruling in June limited state court claims over failure to warn.
  • The judge called the settlement fair and adequate, noting bankruptcy risks for Bayer.

Background

Bayer acquired Monsanto in 2018, inheriting Roundup and associated lawsuits. The World Health Organization classified glyphosate as probably carcinogenic in 2015, while the EPA found it not likely to cause cancer when used as directed. Bayer previously set aside $16 billion for legal costs. The company has removed glyphosate from residential Roundup versions. This settlement follows a Supreme Court ruling that barred state court claims over failure to warn, altering the legal strategy for plaintiffs.

Why it matters

The settlement provides financial certainty for Bayer and compensation for thousands of cancer patients, resolving a major legal dispute. It reflects the impact of a Supreme Court ruling on state court claims and highlights ongoing debates over glyphosate's safety. The deal may influence future litigation and product use, as Bayer continues to sell Roundup in agricultural markets.

What to watch

The decision could be appealed. Bayer will make annual payments into a special fund for up to 21 years. Future claims from people exposed before the settlement proposal may be covered. The legal landscape for Roundup cases may shift due to the Supreme Court ruling and the settlement's terms.

Share this article

Want the full story? Read the original reporting

Read on AP News